Ecopipam
Ecopipam is a pharmaceutical drug with 12 clinical trials. Currently 1 active trials ongoing. Historical success rate of 90.9%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
5
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
90.9%
10 of 11 finished
9.1%
1 ended early
1
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist
A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder
Drug Interaction Study
Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble
Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease
Clinical Trials (12)
Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist
A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder
Drug Interaction Study
Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble
Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension
Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents
Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and Transport
Effects of Ecopipam or Placebo in Adults With Stuttering (Speak Freely)
Ecopipam Treatment of Tourette Syndrome
Safety and Tolerability of the D1 Dopamine Receptor Antagonist Ecopipam in Patients With Lesch-Nyhan Disease
All 12 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 12